EXM continues to work very closely with the relevant Portuguese authorities, especially INFARMED
, regarding our Portuguese activities.
Flowr CEO Vinay Tolia said: "INFARMED
's authorization to plant cannabis at Aljustrel is a major milestone in the development of this project, a cornerstone of our effort to service the global medical cannabis market.
. Deliberacao n.o 144/CD/2012--Norma orientadora para a aceitacao de nomes de medicamentos.
* While Portugal's pharma market is contracting overall, the latest data from Infarmed
show that sales of non-prescription drugs in mass market outlets are increasing.
. Antiepilepticos em geral e valproato de sodio aumento do risco de malformacoes congenitas.
Es importante mencionar la realizacion en Lima del III Foro Internacional de Lucha Contra el Comercio Ilegal de Productos Farmaceuticos y Afines (9-11 de septiembre 2009), que reunio autoridades reguladoras de Brasil (ANVISA), Portugal (INFARMED
), Colombia (INVIMA) y Peru, y distintos representantes de las instituciones que conforman CONTRAFALME: Fiscalia, SUNAT-ADUANAS, Policia Nacional del Peru y DISAS (Direcciones de Salud)/DIRESAS (Direcciones Regionales de Salud).
Care should be taken to redefine clearly the tasks of other structures already in charge of regulating the sector and ensuring quality of care--IGIF, the Directorate General of Health, the National Institute of Pharmaceuticals and Medicine (INFARMED
) and the Institute for Quality in Health (IQS)--so as to limit overlaps.
On February 21, Gaia Pharm received approval of its application to construct an EU GMP compliant cannabis cultivation facility from INFARMED
, a division of the Portuguese Health Ministry, which is responsible for the evaluation, authorization, regulation and control of human medicines as well as health products for the protection of public health.
For allocation to therapeutic groups, according to the anatomic-therapeutic classification of specialties, ATC level 1, ATC level 2, ATC level 4, the information collected in the updated RCM was used, approved by Infarmed
This marketing authorisation was awarded by the National Authority of Medicines and Health Products (Autoridade Nacional do Medicamento e Produtos de Saude, Infarmed
Breakdown of pharmaceutical expenditures Per cent of GDP 1991 1993 1995 Total 1.8 1.9 2.1 of which: NHS 0.7 0.7 0.9 Sub-systems 0.2 0.2 0.2 Co-payments 0.4 0.5 0.5 Over-the-counter and other private spending 0.5 0.5 0.5 Source: INFARMED